BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.
Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.
What's Your Reaction?
